Sarcomatoid Mesothelioma has emerging NIH research funding with 1 grant totaling $1.3M.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Sarcomatoid Mesothelioma. Strongest funded area: Translational / Drug Development. Largest gap: Epidemiology / Natural History.
7 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for sarcomatoid mesothelioma. Existing research activity suggests this may be a viable area for grant applications.
Track funding opportunities for Sarcomatoid Mesothelioma.
Follow this disease to be notified about new NIH grants and funding changes.
Already have an account? Sign in to manage your watchlists.